New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

Today's Free Fly Stories
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | all day >>
07:58 EDTENDPEndo price target raised to $104 from $88 at Canaccord
Canaccord raised its price target on Endo to $104 from $88 following strong Q4 results. The firm cited strength in all business segments, potential for upside to guidance, and its recent sale of AMS, which gives it cash for acquisitions. Canaccord reiterated its Buy rating on Endo shares.
07:57 EDTANTMAnthem warned in 2013 about cybersecurity weakness, FT says
Subscribe for More Information
07:56 EDTBSXBoston Scientific remains a top pick at JPMorgan
Subscribe for More Information
07:56 EDTCAHCardinal Health price target raised to $105 from $90 at Argus
Argus increased its price target on Cardinal based on what the firm sees as the company's solid Q2 results and its beneficial acquisition of Johnson & Johnsonís (JNJ) Cordis business. Argus expects Cordis to provide Cardinal with a new growth driver with higher margins. Argus keeps a Buy rating on Cardinal.
07:55 EDTSTOStatoil upgraded to Buy from Accumulate at Tudor Pickering
Subscribe for More Information
07:55 EDTBPBP downgraded to Hold from Accumulate at Tudor Pickering
07:55 EDTN.Y. FX Outlook: EUR-USD managed fresh lows of 1.1155
Subscribe for More Information
07:53 EDTMNSTMonster Beverage price target raised to $164 from $145 at Argus
Subscribe for More Information
07:52 EDTLHLabCorp upgraded to Buy at Canaccord
As previously reported, Canaccord upgraded LabCorp to Buy form Hold as they believe there is upside to growth estimates following its acquisition of Covance, new contract wins, and higher volumes. Canaccord raised its price target to $145 from $100 on LabCorp shares.
07:51 EDTDGXQuest Diagnostics upgraded to Buy at Canaccord
Subscribe for More Information
07:50 EDTGOOG, GOOGLGoogle much better positioned than many believe, says UBS
Subscribe for More Information
07:49 EDTTSTTheStreet valuation attractive, says B. Riley
B. Riley views TheStreet's current price as an excellent entry point. The analyst believes management can leverage the sales channels to grow both The Deal and BoardEx and reiterates its Buy rating ahead of Wednesday's Q4 report.
07:49 EDTTGTTarget to revamp grocery unit, WSJ says
Subscribe for More Information
07:49 EDTPCYCPharmacyclics downgraded at Wedbush
Subscribe for More Information
07:48 EDTBBYBest Buy up 4.5% after Q4 earnings beat, dividend hike
07:48 EDTJECJacobs Engineering announces $300M in total contracts over past six months
Subscribe for More Information
07:45 EDTTreasury Market Outlook: bonds and stocks are lower around the world
Subscribe for More Information
07:44 EDTBBYBest Buy targeting $400M in annualized savings from phase 2 of 'Renew Blue'
Since the 3Q15 earnings release, Renew Blue annualized cost reductions have increased an additional $55M, bringing the total Renew Blue annualized cost reductions to $1.02B, Best Buy stated. In FY16, the company is launching Phase Two of its Renew Blue cost reduction and gross profit optimization program with a target of approximately $400Min annualized operating income improvement over three years, including the remaining benefit of approximately $250M from the companyís previously discussed returns, replacements and damages opportunity. These savings will be structural in nature and will be driven by streamlined processes and operational efficiencies that will be primarily enabled through investments in systems.
07:42 EDTCFA Society of Cleveland to hold a discussion
Subscribe for More Information
07:42 EDTPANWPalo Alto price target raised to $165 from $120 at Stifel
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | all day >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use